Zydus Wellness Ltd
Wed 21/05/2025,15:59:56 | NSE : ZYDUSWELL
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1937.50
Previous Close
₹ 1920.90
Volume
225578
Mkt Cap ( Rs. Cr)
₹12534.26
High
₹ 2018.00
Low
₹ 1919.00
52 Week High
₹ 2484.00
52 Week Low
₹ 1493.20
Book Value Per Share
₹ 863.45
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Zydus Wellness Ltd
Your Vote -
Buy
22.50%
Hold
43.33%
Sell
34.17%
22.50%
120 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
1969.80
11
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
11
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Zydus Wellness Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Zydus Wellness Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates
-
Zydus Wellness Ltd. - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Zydus Wellness Ltd. - Alteration Of Capital and Fund Raising-XBRL
-
Zydus Wellness Ltd. - Outcome of Board Meeting-XBRL
-
Zydus Wellness Ltd. - Appointment
-
Zydus Wellness Ltd. - Appointment
-
Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Zydus Wellness Ltd. - Appointment Of Secretarial Auditors
-
Zydus Wellness Ltd. - Record Date
-
Zydus Wellness Ltd. - Friday, July 11, 2025
-
Zydus Wellness Ltd. - Press Release
-
Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Zydus Wellness Ltd. - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Zydus Wellness Ltd. - Investor Presentation
-
Zydus Wellness Ltd. - Stock split
-
Zydus Wellness Ltd. - Corporate Action-Board approves Dividend
-
Zydus Wellness Ltd. - Audited Financial Results For The Year Ended On March 31, 2025
-
Zydus Wellness Ltd. - Dividend
-
Zydus Wellness Ltd. - Board Meeting Outcome for Audited Financial Results For The Financial Year Ended On March 31, 2025
-
Zydus Wellness Q4 net profit down 36.49% at Rs 4.70 cr
-
Zydus Wellness Ltd. - Outcome of Board Meeting
-
Zydus Wellness Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates
-
Zydus Wellness Ltd. - Board Meeting Intimation
-
Zydus Wellness Ltd. - Board Meeting Intimation for Approval Of Financial Results, Recommendation Of Dividend And Proposal For
-
Zydus Wellness Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Zydus Wellness Ltd. - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Zydus Wellness Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Zydus Wellness Ltd. - Receipt Of Cautionary Email From NSE And BSE
-
Zydus Wellness Ltd. - Action(s) taken or orders passed
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Trading Window-XBRL
-
Zydus Wellness Ltd. - Trading Window
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Action(s) initiated or orders passed
-
Zydus Wellness Ltd. - Disclosure Of Receipt Of Show Cause Notice From DGGI
-
Zydus Wellness Ltd. - Updates
-
Zydus Wellness Ltd. - Intimation Of ESG Score
-
Zydus Wellness Ltd. - Action(s) taken or orders passed
-
Zydus Wellness Ltd. - Receipt Of Assessment Order Under CGST Act, 2017
-
Stock update: Zydus Wellness Q3FY25 (Consolidated) result update
-
Zydus Wellness
-
Zydus Wellness
-
Stock update: Zydus Wellness
-
Stock update: Zydus Wellness Q2FY2024 (Consolidated) result update
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness Q3FY2023 (Consolidated) result update
-
Zydus Wellness Q2FY2023 (Consolidated) result update
-
Zydus Wellness Q1FY2023 (Consolidated) result update
-
Zydus Wellness
-
Zydus Wellness
-
Zydus receives final approval from USFDA for Nitroglycerin Sublingual Tablets
-
Zydus Wellness
-
Zydus Lifesciences gets Indian regulator nod for Desidustat
-
Zydus Wellness Q3FY2022 (consolidated) result update
-
Zydus Wellness: Good performance
-
Zydus Wellness - revenues came in line
-
Zydus Wellness: Q4FY2021 result update
-
Zydus Wellness register strong performance in Q4
-
Zydus Wellness
-
Zydus Wellness: Strong Q3
-
Zydus Wellness Q3FY21 Result First cut
-
Zydus Wellness: Soft Q2
-
Zydus Wellness Q2FY2021 first cut
-
Zydus Wellness
-
Zydus Wellness - Stock update
-
Zydus Wellness raises Rs. 650 crore through issuance of shares to QIBs
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
GMR Infrastructure, Zydus Wellness
-
Oil and Natural Gas Corporation, Zydus Wellness
-
Zydus Wellness
-
Zydus Wellnes Ltd
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
CARE Ratings revises and reaffirms the rating of Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness
-
Zydus Wellness: Stock Update
-
Zydus Wellness promoter pledged 6.3% stake with Kotak Mahindra Investment
-
Zydus Wellness gets CCI nod for acquisition of Heinz India
-
Zydus Wellness plans to raise funds
-
Zydus Wellness to acquire Heinz India
-
Kraft Heinz agrees to sell Complan to Zydus Wellness
-
Zydus Wellness: Stock Update
-
Zydus Wellness: Stock update - Q1FY2019 result
-
Zydus Wellness reports strong performance
-
Zydus Wellness grew by 22% in Q3FY18
-
Zydus wellness Q2 revenues grow in double digit
-
Zydus Wellness Q2 revenues grew by 11.0%
-
Zydus Wellness Q1FY2018 stock update
Key fundamentals
Evaluate the intrinsic value of Zydus Wellness Ltd stock
Name | March-25 | March-24 | March-23 | March-22 | March-21 |
---|---|---|---|---|---|
Assets | 4163.6 | 4085.9 | 4034.28 | 4046.18 | 4069.04 |
Liabilities | 4163.6 | 4085.9 | 4034.28 | 4046.18 | 4069.04 |
Equity | 63.6 | 63.6 | 63.63 | 63.63 | 63.63 |
Gross Profit | 36.6 | 33 | 38.31 | -5.32 | -49.72 |
Net Profit | 30.6 | 33.7 | 66.42 | 12.7 | -182.14 |
Cash From Operating Activities | 45.7 | 26 | 36.67 | -16.27 | -51.95 |
NPM(%) | 10.45 | 13.76 | 26.41 | 5.87 | -160.01 |
Revenue | 292.6 | 244.8 | 251.48 | 216.25 | 113.83 |
Expenses | 256 | 211.8 | 213.17 | 221.57 | 163.55 |
ROE(%) | 0.55 | 0.61 | 1.2 | 0.23 | -3.31 |
Corporate Action
XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
---|---|---|---|---|
6 | 60 | 0 | 1832.6 | |
19 Jul 2024 | 5 | 50 | 0 | 1729.2 |
21 Jul 2023 | 5 | 50 | 0 | 1481.15 |
14 Jul 2022 | 5 | 50 | 0 | 1665.6 |
14 Jul 2021 | 5 | 50 | 0 | 2108.85 |
19 Mar 2020 | 5 | 50 | 0 | 1415.15 |
0 | 0 | 0 | 1471.1 | |
17 Jul 2019 | 5 | 50 | 0 | 1328.65 |
18 Jul 2018 | 8 | 80 | 0 | 1254.4 |
09 Mar 2017 | 6.5 | 65 | 0 | 821.75 |
16 Mar 2016 | 6.5 | 65 | 0 | 700.3 |
16 Jul 2015 | 6 | 60 | 0 | 1000.35 |
03 Jul 2014 | 6 | 60 | 0 | 525.1 |
18 Jul 2012 | 5 | 50 | 0 | 364.55 |
22 Jun 2011 | 4 | 40 | 0 | 579.5 |
08 Jul 2010 | 3 | 30 | 0 | 397.5 |
Peers
Other companies within the same industry or sector that are comparable to Zydus Wellness Ltd
Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
---|---|---|---|---|---|---|
Sundrop Brands Ltd | 800.35 | -0.83 | 0.00 | 4794.48 | -291.51 | 0.00 |
Anik Industries Ltd | 112.11 | 0.07 | 0.00 | 5460.36 | 1.09 | 0.00 |
BCL Industries Ltd | 39.42 | 0.95 | 12.55 | 53583.50 | 305.92 | 0.63 |
AVT Natural Products Ltd | 66.03 | 1.82 | 22.46 | 29961.12 | 349.93 | 1.21 |
Company Info
Mr Chintal D Sakaria, has been appointed as Company Secretary and Compliance Officer wef from November 14, 2003. 2009 - Company name has been changed from Carnation Nutra-Analogue Foods Ltd to Zydus Wellness Ltd. 2010 -Zydus Wellness - Board recommends Dividend @ 30% i.e. Rs. 3/- per Equity Share on 39,072,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2010. 2011 - Zydus Wellness recommends Dividend Rs. 4/- (At the rate of 40%) per equity share on 39072089 equity shares of Rs. 10/- each for the financial year ended on March 31, 2011 2012 -Elkana Ezekiel joins Zydus Wellness as CEO - ydus Wellness recommends Dividend of dividend @ 50% i.e. Rs. 5/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2012. 2013 - The Company has declared interim dividend @ 60% i.e. Rs. 6/- per Equity Share. -The Registered office of the company has been changed from Zydus Tower, Satellite Cross Roads, Sarkhej-Gandhinagar Highway, Ahmedabad - 380 015 to House No. 6 & 7, Sigma Commerce Zone, Nr. Iscon temple, Sarkhej - Gandhinagar Highway, Ahmedabad - 380 015. 2014 - The Board of Directors appointed Dr. Sharvil P. Patel as the Chairman of the Board. - The Company has recommended a dividend @ 60% i.e. Rs. 6/- per Equity Share. 2016 -Zydus bags approval for Amantadine Capsules -Zydus acquires Melgain from Issar Pharma 2017 - The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg. 2018 The company inform that the members holding shares as on the cut-off date, i.e. July 26, 2018, will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. 2019 -This is to inform that Hon'ble National Company Law Tribunal, Bench at Ahmedabad has passed an order dated May 10, 2019 approving the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India Private Limited (Heinz) with Zydus Nutritions Limited (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the Company. 2022 -A moment of pride! ZWPL recognised among top manufacturing Facilities. 2024 -Zydus Wellness join hands with Shahid Kapoor for product launch. -Zydus Wellness enters into packaged foods segment.
Mr Chintal D Sakaria, has been appointed as Company Secretary and Compliance Officer wef from November 14, 2003. 2009 - Company name has been changed from Carnation Nutra-Analogue Foods Ltd to Zydus Wellness Ltd. 2010 -Zydus Wellness - Board recommends Dividend @ 30% i.e. Rs. 3/- per Equity Share on 39,072,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2010. 2011 - Zydus Wellness recommends Dividend Rs. 4/- (At the rate of 40%) per equity share on 39072089 equity shares of Rs. 10/- each for the financial year ended on March 31, 2011 2012 -Elkana Ezekiel joins Zydus Wellness as CEO - ydus Wellness recommends Dividend of dividend @ 50% i.e. Rs. 5/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2012. 2013 - The Company has declared interim dividend @ 60% i.e. Rs. 6/- per Equity Share. -The Registered office of the company has been changed from Zydus Tower, Satellite Cross Roads, Sarkhej-Gandhinagar Highway, Ahmedabad - 380 015 to House No. 6 & 7, Sigma Commerce Zone, Nr. Iscon temple, Sarkhej - Gandhinagar Highway, Ahmedabad - 380 015. 2014 - The Board of Directors appointed Dr. Sharvil P. Patel as the Chairman of the Board. - The Company has recommended a dividend @ 60% i.e. Rs. 6/- per Equity Share. 2016 -Zydus bags approval for Amantadine Capsules -Zydus acquires Melgain from Issar Pharma 2017 - The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in strengths of 25 mg, 50 mg and 100 mg. 2018 The company inform that the members holding shares as on the cut-off date, i.e. July 26, 2018, will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. will be entitled to exercise their voting rights electronically or at the venue of the Annual General Meeting. 2019 -This is to inform that Hon'ble National Company Law Tribunal, Bench at Ahmedabad has passed an order dated May 10, 2019 approving the Scheme of Amalgamation (Scheme) between two subsidiaries, Heinz India Private Limited (Heinz) with Zydus Nutritions Limited (ZNL). Upon amalgamation, Heinz has ceased to be in existence and also to be the subsidiary of the Company. 2022 -A moment of pride! ZWPL recognised among top manufacturing Facilities. 2024 -Zydus Wellness join hands with Shahid Kapoor for product launch. -Zydus Wellness enters into packaged foods segment.
Read More
Parent Organisation
Zydus Wellness Ltd.
Founded
01/11/1994
Managing Director
Dr.Sharvil P Patel
NSE Symbol
ZYDUSWELLEQ
FAQ
The current price of Zydus Wellness Ltd is ₹ 1969.80.
The 52-week high for Zydus Wellness Ltd is ₹ 2018.00 and the 52-week low is ₹ 1919.00.
The market capitalization of Zydus Wellness Ltd is currently ₹ 12534.26. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Zydus Wellness Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Zydus Wellness Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zydus Wellness Ltd shares.
The CEO of Zydus Wellness Ltd is Dr.Sharvil P Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.